View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 16, 2017

Leman Micro Devices unveils health monitoring app to measure vital signs

Switzerland-based Leman Micro Devices (LMD) has unveiled a smartphone-integrated solution Health Sensor and App, which combines a sensor and software to measure vital signs such as blood pressure with medical accuracy.

Switzerland-based Leman Micro Devices (LMD) has unveiled a smartphone-integrated solution Health Sensor and App, which combines a sensor and software to measure vital signs such as blood pressure with medical accuracy.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The firm has already conducted trials to evaluate the accuracy of the system and intends to submit for approval from regulators such as the US Food and Drug Administration (FDA) later this year.

Equipped with Riva-Rocci technique, the app eliminates the requirement for a cuff on the arm to measure blood pressure. It instead instructs the user on how hard to push the finger against the firm's sensor that is built into the smartphone.

LMD chief executive officer Mark-Eric Jones said:  “The world is ready for smartphones that come with a built-in medically-accurate heath monitoring system, rather than current products which are not approved and often inaccurate.

"Most wearable devices do not measure health at all, only activity, while other solutions carry a hefty price tag."

The app is factory-loaded in the smartphone, which does not require any calibration for its life or expense from the user.

" The world is ready for smartphones that come with a built-in medically-accurate heath monitoring system."

Jones added: “Our product is proven in the lab and already the FDA has ruled that it is our device, not the smartphone itself which is the regulated element, in this instance, the smartphone is regarded as an accessory."

The app additionally provides medically-accurate readings of body temperature, blood oxygen saturation, heart rate and respiration rate.

The measurements can be performed anywhere at any time within 60 seconds by following simple instructions and without any additional accessories.


Image: LMD's medically accurate smartphone integrated Health Sensor and App. Photo: courtesy of Leman Micro Devices.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network